期刊文献+

槲皮素对慢性髓系白血病伊马替尼耐药细胞株的作用及机制研究 被引量:5

Effects of Quercetin on Chronic Myeloid Leukemia Cell Line Resistant to Imatinib and Its Mechanism
下载PDF
导出
摘要 目的:探讨槲皮素对慢性髓系白血病伊马替尼耐药细胞株的生长抑制作用及其机制。方法:台盼蓝染色法检测细胞活力,流式细胞术检测细胞凋亡和细胞周期,Western blot检测相关蛋白的表达水平。结果:25μmol/L槲皮素对伊马替尼耐药的K562细胞株K562R和K562G具有与伊马替尼敏感细胞株K562相似的生长抑制和诱导凋亡作用,且不改变BCR-ABL的表达水平。25μmol/L槲皮素处理24 h后,K562、K562R和K562G细胞的G_2/M期百分比明显增加。槲皮素能使γ-H2AX水平明显增高,且上调JNK的磷酸化水平。结论:槲皮素单药对伊马替尼耐药细胞株具有生长抑制和诱导凋亡作用,使细胞停滞于G_2/M期,其机制可能与上调JNK磷酸化水平导致DNA双链损伤相关。 Objective: To explore the growth inhibitory effect of quercetin on imatinib-resistant chronic myeloid leukemia cell lines and to clarify its involved mechanisms. Methods: The cell viability was detected by trypan blue Staining, percentage of apoptotic cells and cell cycle distribution were detected by flow cytometry, the protein expression was detected by Western blot. Results : Both inhibitory effect of proliferation and apoptosis-inducing effect were similar between the imatinib-resistant and -sensitive cell lines treated with 25μmol/L quercetin for 24 hours and with arrest of cell cycle at G2/M phase. Quercetin could not change the expression of BCR-ABL. The expression of γ-H2AX was markedly enhanced and the phosphorylation of JNK up-regulated by quercetin in both imatinib-resistant and imatinib-sensitive cell lines. Conclusion: The growth of imatinib-resistant cells can be inhibited by quercetin, and the apoptosis of cells can be induced by quercetin, which may be related to cell cycle arrest in G2/M. The DNA damage and up-regula- tion of p-JNK may be involved in these processes.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2017年第2期346-352,共7页 Journal of Experimental Hematology
关键词 慢性髓系白血病 槲皮素 伊马替尼耐药 细胞周期阻滞 DNA损伤 JNK chronic myeloid leukemia quercetin imatinib resistance cell cycle arrest DNA damage JNK
  • 相关文献

参考文献3

二级参考文献38

  • 1Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med, 1996,2:561-566.
  • 2Gambacorti-Passenini C, le Coutre P, Mologni L, et al. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis. Blood Cells Mos Dis, 1997,23:380-394.
  • 3Corrol M, Ohno-Jones S, Tamura S, et al. CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood,1997,90:4947-4952.
  • 4Deininger MW, Goldman JM, Lydon N, et al. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. Blood,1997,90:3691-3698.
  • 5Gorre ME, Mahammed M, Ellwod K ,et al. Clinical resistance to STI571 cancer therapy caused by BCR-ABL gene mutation or amplification. Blood,2001,293:876-880.
  • 6Tipping AJ, Mahon FX, Lagarde V, et al. Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells. Blood,2001,98:3864-3867.
  • 7Yang CZ, Luan FJ,Xiong DS,et al. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicine. Acta Pharmacologica Sinica, 1995,16: 333-337.
  • 8Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983,65: 55-63.
  • 9Gorre ME,Mahammed M,Ellwod K,et al.Clinical resistance to STI571 cancer therapy caused by BCR-ABL gene mutation or amplification.Blood,2001,93:876-880.
  • 10Noonan KE,Beck C,Holzmayer TA,et al.Quantitation analysis of MDR1(multidrug resistance) gene expression in human tumor by polymerase chain reaction.Proc Natl Acad Sci U S A,1990,87:7160-7168.

共引文献21

同被引文献52

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部